Bristol Myers Squibb (BMY) Dividends payables (2009 - 2015)

Bristol Myers Squibb (BMY) has reported Dividends payables for 7 consecutive years, with $655.0 million the latest figure, recorded in Q4 2015.

• On a quarterly basis, Dividends payables rose 1.55% year-over-year to $655.0 million in Q4 2015; TTM through Dec 2015 was $655.0 million, a 1.55% increase from a year earlier, with the FY2015 full-year figure at $655.0 million, up 1.55% from the prior year.
• Dividends payables was $655.0 million for Q4 2015 at Bristol Myers Squibb, up from $636.0 million in the prior quarter.
• Over five years, Dividends payables peaked at $655.0 million in Q4 2015 and troughed at $578.0 million in Q1 2011.
• A 5-year average of $612.2 million and a median of $608.5 million in 2012 frame the typical range for Dividends payables.
• The widest YoY moves for Dividends payables: up 4.62% in 2013, down 1.34% in 2013.
• Over 5 years, Dividends payables stood at $597.0 million in 2011, then rose by 1.51% to $606.0 million in 2012, then grew by 4.62% to $634.0 million in 2013, then advanced by 1.74% to $645.0 million in 2014, then grew by 1.55% to $655.0 million in 2015.
• The last three Dividends payables figures came in at $655.0 million (Q4 2015), $636.0 million (Q3 2015), and $634.0 million (Q2 2015), per Business Quant data.